72.19.Z - Scientific research and development activities
26.40.Z - Manufacture of electronic consumer products
32.50.Z - Production of medical devices, instruments, and products, including dental products
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -2,6 | -2,5 | 4,1 | |
Gross profit (loss) | -1,3 | -1,6 | -23,7 | |
EBITDA | -1,2 | -1,5 | -22 | |
Short time liabilities | 2,2 | 2,8 | 24,1 | |
Other operating costs | 0 | 0 | -71,9 | |
Equity capital | 0,2 | -1,1 | 0,6 | 153 |
Operating profit (EBIT) | -1,3 | -1,5 | -22 | |
Assets | 1,4 | 2,4 | 5,7 | 137,5 |
Net profit (loss) | -0,4 | -1,3 | -1,2 | 6,8 |
Cash | 1,6 | 0,2 | -88,7 | |
Net income from sale | 0 | 0 | -93,8 | |
Liabilities and provisions for liabilities | 1,2 | 3,5 | 5,2 | 48,9 |
Working assets | 0,9 | 1,8 | 4,7 | 165,7 |
Other income costs | 1,4 | 1 | -28,3 | |
Depreciation | 0 | 0 | 23,2 | |
Basic operational activity income | 0 | -100 | ||
% | % | % | p.p. | |
Profitability of capital | -179,5 | 119,4 | -210 | -329,4 |
Equity capital to total assets | 14,5 | -43,9 | 9,8 | 53,7 |
Gross profit margin | -39 029 | -784 614,3 | -745 585,3 | |
EBITDA Margin | -38 424,1 | -761 531,4 | -723 107,3 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 250 233 | 5 045 490 | 4 795 257 | |
Current financial liquidity indicator | 0.7957195043563843 | 1.7041741609573364 | 0,9 | |
Net dept to EBITDA | -1.5225863456726074 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane